| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K48334597 |
| PharmacoGx | BRD-K48334597 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SPATA31E1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | FNDC9 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | TMEM42 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | PAWR | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | DHX9 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | MRGPRD | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | C3orf70 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | PODNL1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | C12orf66 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | NRXN1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
